DBV Technologies (DBVT) Gross Margin (2020 - 2026)
DBV Technologies (DBVT) reported Gross Margin of 433.33% for Q1 2026, down 49583.0% year-over-year from N/an in Q1 2025, and down 288.73% quarter-over-quarter from 111.47% in Q4 2025.
DBV Technologies (DBVT) Gross Margin (2020 - 2026) Analysis & Trends
DBV Technologies (DBVT) has 7 years of Gross Margin data on file, last reported at 433.33% in Q1 2026.
- Gross Margin for Q1 2026 came in at 433.33%, down 49583.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 34.18% (down 7208.0% YoY), and the FY2025 annual result was 42.83%, up 689.0% from the prior year.
- Gross Margin retreated to 433.33% in Q1 2026 per DBVT's latest filing, from 111.47% in the prior quarter.
- Over five years, Gross Margin peaked at 96.09% in Q4 2022 and troughed at 433.33% in Q1 2026.
- A 5-year average of 23.81% and a median of 62.5% in 2025 frame the typical range for Gross Margin.
- The sharpest annual moves came in 2025 and 2026: Gross Margin surged 5633 bps in 2025, then slumped 49583 bps in 2026.
- A 5-year view of Gross Margin shows it stood at 96.09% in 2022, then retreated by 6 bps to 90.7% in 2023, then slumped by 75 bps to 22.5% in 2024, then tumbled by 595 bps to 111.47% in 2025, then sank by 289 bps to 433.33% in 2026.
- Business Quant data shows DBVT's Gross Margin at 433.33% in Q1 2026, 111.47% in Q4 2025, and 57.53% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 79.04% |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 86.85% |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | DBV Technologies | 7.53 Bn | 7.30 Bn | -3.90 Mn | -433.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -433.33% |
| Dec 31, 2025 | -111.47% |
| Sep 30, 2025 | 57.53% |
| Jun 30, 2025 | 71.40% |
| Mar 31, 2025 | 62.50% |
| Dec 31, 2024 | 22.50% |
| Sep 30, 2024 | 51.59% |
| Jun 30, 2024 | 15.07% |
| Mar 31, 2024 | 46.13% |
| Dec 31, 2023 | 90.70% |
| Sep 30, 2023 | 72.05% |
| Jun 30, 2023 | 77.45% |
| Mar 31, 2023 | 80.22% |
| Dec 31, 2022 | 96.09% |
| Sep 30, 2022 | 92.33% |
| Jun 30, 2022 | 32.18% |
| Mar 31, 2022 | 81.78% |
| Mar 31, 2021 | 75.21% |
| Mar 31, 2020 | -54.60% |